Profile data is unavailable for this security.
About the company
Jiangsu Cowin Biotech Co Ltd is a China-based company mainly engaged in the research and development, production and sales of molecular detection products. The Company is also engaged in molecular testing services. The Company's main products include molecular detection enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents, and molecular diagnostic kits. The Company's products are primarily used in cell therapy, research institutions, clinical diagnostics, cell biology, animal quarantine, forensic testing, and the screening and diagnosis of gastrointestinal diseases and respiratory infectious diseases. The Company mainly conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)167.17m
- Net income in CNY-137.72m
- Incorporated2010
- Employees833.00
- LocationJiangsu Cowin Biotech Co LtdNo. 18 Zelan RoadMedical High tech ZoneTAIZHOU 225311ChinaCHN
- Phone+86 52 386200880
- Fax+86 52 386200880
- Websitehttps://www.cwbio.com/
More ▼
Mergers & acquisitions
| Acquired company | 688426:SHH since announced | Transaction value |
|---|---|---|
| Shanghai Haoweitai Bio-Technology Co Ltd | -9.57% | 2.51m |
Data delayed at least 15 minutes, as of Feb 11 2026.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guangzhou LBP Medicine Scnc&Tech Co Ltd | 371.03m | -19.11m | 2.64bn | 796.00 | -- | 2.15 | -- | 7.11 | -0.2042 | -0.2042 | 3.97 | 13.10 | 0.2761 | 1.55 | 1.71 | 466,121.80 | -1.49 | 3.50 | -1.55 | 3.78 | 63.03 | 72.02 | -5.41 | 9.79 | 7.80 | -- | 0.0118 | 32.69 | -5.33 | 5.80 | -46.85 | -22.05 | -7.83 | -- |
| Guangzhou Jet Bio-Filtration Co Ltd | 566.02m | 79.32m | 2.65bn | 1.08k | 35.12 | 2.14 | -- | 4.67 | 0.5367 | 0.5367 | 3.75 | 8.81 | 0.335 | 2.65 | 4.37 | 523,125.40 | 4.81 | 7.56 | 5.10 | 8.33 | 41.07 | 36.85 | 14.35 | 16.26 | 6.46 | 9.35 | 0.2334 | 21.03 | 20.63 | 17.68 | 107.51 | 1.76 | 14.94 | -27.21 |
| Jiangsu Cowin Biotech Co Ltd | 167.17m | -137.72m | 2.87bn | 833.00 | -- | 2.06 | -- | 17.14 | -1.24 | -1.24 | 1.51 | 12.36 | 0.1038 | 1.81 | 2.52 | 200,679.40 | -8.91 | 2.79 | -9.42 | 2.97 | 45.15 | 68.50 | -85.88 | 11.47 | 13.54 | -- | 0.0156 | 32.07 | -26.54 | 11.23 | -86.25 | -- | 34.36 | -- |
| Maider Medical Industry Equipment Co Ltd | 279.92m | -18.77m | 2.90bn | 657.00 | -- | 3.60 | -- | 10.36 | -0.1053 | -0.1053 | 1.68 | 4.85 | 0.249 | 1.07 | 2.08 | 426,058.40 | -3.34 | 5.79 | -4.30 | 6.86 | 34.68 | 49.32 | -13.40 | 16.23 | 1.91 | -- | 0.0705 | 63.92 | -42.77 | 5.58 | -120.02 | -- | 22.08 | -- |
| Jinan High-tech Development Co Ltd | 324.74m | -841.90m | 3.02bn | 565.00 | -- | 68.76 | -- | 9.29 | -1.03 | -1.03 | 0.3748 | 0.0496 | 0.142 | 0.4155 | 0.8567 | 574,762.40 | -39.48 | -8.01 | -161.56 | -27.24 | 16.82 | 28.09 | -277.95 | -31.77 | 0.8954 | -- | 0.283 | -- | -48.02 | -26.91 | -747.31 | -- | -48.67 | -- |
| Shanghai General Hthy Info & Tech Co Ltd | 393.61m | 8.92m | 3.05bn | 355.00 | 348.92 | 2.83 | -- | 7.76 | 0.0644 | 0.0644 | 2.89 | 7.94 | 0.2601 | 3.05 | 0.7735 | 1,108,747.00 | 0.6908 | 7.98 | 0.9681 | 10.00 | 29.15 | 50.08 | 2.66 | 26.00 | 1.82 | 4.30 | 0.1357 | 15.97 | 3.51 | 1.18 | -45.80 | -18.76 | 7.19 | -- |
| Chemclin Diagnostics Co Ltd | 353.33m | 56.49m | 3.16bn | 629.00 | 56.01 | 2.24 | -- | 8.95 | 0.1407 | 0.1407 | 0.8799 | 3.51 | 0.1957 | 1.06 | 16.07 | 561,724.90 | 3.13 | 9.46 | 3.44 | 10.57 | 66.36 | 73.98 | 15.99 | 30.72 | 6.62 | -- | 0.1472 | 44.55 | -2.03 | -0.8218 | -13.77 | -2.00 | 14.24 | -- |
| Kontour XiAn Medical Technology Co Ltd | 332.92m | 88.40m | 3.20bn | 311.00 | 36.17 | 4.65 | -- | 9.60 | 1.09 | 1.09 | 4.10 | 8.47 | 0.4356 | 2.73 | 38.35 | 1,070,470.00 | 11.45 | 13.82 | 12.97 | 15.72 | 77.13 | 79.18 | 26.29 | 30.37 | 4.51 | 8.00 | 0.0595 | 28.58 | 17.06 | 16.85 | 17.07 | 11.22 | 37.93 | -- |
Data as of Feb 11 2026. Currency figures normalised to Jiangsu Cowin Biotech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
39.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 4.82m | 18.85% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 2.01m | 7.85% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2025 | 1.67m | 6.52% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 538.38k | 2.11% |
| SWS MU Fund Management Co., Ltd.as of 30 Jun 2025 | 445.63k | 1.74% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 222.70k | 0.87% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 183.30k | 0.72% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 121.39k | 0.48% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 90.09k | 0.35% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 83.31k | 0.33% |
More ▼
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
